Press releases | UCB
UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

27 Sep 2022

FINTEPLA[®▼] (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet Syndrome

Read More
23 Sep 2022

Disposal of own shares

Read More
22 Sep 2022

UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting

Read More
20 Sep 2022

European Medicine Agency Accepts Marketing Authorization Applications for Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis

Read More
9 Sep 2022

Disposal of own shares

Read More
9 Sep 2022

ASBMR 2022: 3D modelling of hip DXA scans in postmenopausal women with osteoporosis reveals superior improvements in bone density of romosozumab versus controls

Read More

Stay up-to-date on the latest news and information from UCB